Experience the freedom to choose a dosing schedule that works for you         By choosing COPAXONE® (glatiramer acetate injection), you have put your trust in the #1 prescribed brand for relapsing MS in the US.1* Introducing new 3-times-a-week COPAXONE® 40 mg.             Consider the freedom of injection-free weekends   With new 3-times-a-week COPAXONE® 40 mg, you have the freedom to choose a dosing schedule that works for you. For example, if you want your weekends to be injection free, you can choose Monday, Wednesday, and Friday as your injection days, with injections at least 48 hours apart.2         Have you talked to your doctor about 3-times-a-week COPAXONE® 40 mg?     CLICK HERE for a Doctor Discussion Guide to help you prepare for your appointment.     Get on board!     Be Bold.  Take control of your relapsing MS by choosing a therapy with proven results.       Call Shared Solutions® at 1-800-887-8100 to get more details about 3-times-a-week COPAXONE® 40 mg. Be True.  Make a commitment—and stay the course with a therapy you trust.       Be You.  Arrange your treatment around your life—not your life around your treatment.                     COPAXONE® is indicated for the treatment of patients with relapsing forms of multiple sclerosis.   Important Safety Information   Do not take COPAXONE® if you are allergic to glatiramer acetate or mannitol.   Some patients report a short-term reaction right after injecting COPAXONE®. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms generally appear within minutes of an injection, last about 15 minutes, and do not require specific treatment. During the postmarketing period, there have been reports of patients with similar symptoms who received emergency medical care. If symptoms become severe, call the emergency phone number in your area. Call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, or severe pain at the injection site. If any of the above occurs, do not give yourself any more injections until your doctor tells you to begin again.   Chest pain may occur either as part of the immediate postinjection reaction or on its own. This pain should only last a few minutes. You may experience more than one such episode, usually beginning at least one month after starting treatment. Tell your doctor if you experience chest pain that lasts for a long time or feels very intense.   A permanent indentation under the skin (lipoatrophy or, rarely, necrosis) at the injection site may occur, due to local destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes.   The most common side effects in studies of COPAXONE® are redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These are not all of the possible side effects of COPAXONE®. For a complete list, ask your doctor or pharmacist. Tell your doctor about any side effects you have while taking COPAXONE®.   You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.   Please see full Prescribing Information.         *Based on total number of prescriptions for relapsing forms of MS (IMS National Rx Audit, February 2014).   References: 1. IMS Health National Prescription Audit, February 2014. Data proprietary to IMS Health. 2. COPAXONE® (glatiramer acetate injection) prescribing information. Rev 1/2014 Teva Neuroscience, Inc.   Privacy Notice | One-click Unsubscribe | Terms of Use     COPAXONE® is a registered trademark of Teva Pharmaceutical Industries Ltd. Shared Solutions® is a registered service mark of Teva Neuroscience, Inc. © 2014 Teva Neuroscience, Inc. COP-41603 Teva Neuroscience, Inc., COPAXONE® Marketing, 11100 Nall Avenue, Overland Park, KS 66211